Acquired resistance to combination treatment with TMZ and ABT-888 is mediated by both BER and HR DNA repair pathways

被引：0
|
作者：
Liu, Xuesong
Han, Edward K.
Anderson, Mark G.
Shi, Yan
Semizarov, Dimitri
Wang, Gang
McGonigal, Thomas
Roberts, Lisa
Iasko, Ioren
Palma, Joann
Zhu, Gui-Dong
Penning, Thomas
Rosenberg, Saul
Giranda, Vincent
Luo, Yan
Leverson, Joel
Johnson, Eric F.
Shoemaker, Alexander R.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-A161
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A161
引用
收藏
页数：2
相关论文
共 4 条
  • [1] Acquired Resistance to Combination Treatment with Temozolomide and ABT-888 Is Mediated by Both Base Excision Repair and Homologous Recombination DNA Repair Pathways
    Liu, Xuesong
    Han, Edward K.
    Anderson, Mark
    Shi, Yan
    Semizarov, Dimitri
    Wang, Gang
    McGonigal, Thomas
    Roberts, Lisa
    Lasko, Loren
    Palma, Joann
    Zhu, Gui-dong
    Penning, Thomas
    Rosenberg, Saul
    Giranda, Vincent L.
    Luo, Yan
    Leverson, Joel
    Johnson, Eric F.
    Shoemaker, Alexander R.
    MOLECULAR CANCER RESEARCH, 2009, 7 (10) : 1686 - 1692
  • [2] Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer
    Maha Hussain
    Michael A. Carducci
    Susan Slovin
    Jeremy Cetnar
    Jiang Qian
    Evelyn M. McKeegan
    Marion Refici-Buhr
    Brenda Chyla
    Stacie P. Shepherd
    Vincent L. Giranda
    Joshi J. Alumkal
    Investigational New Drugs, 2014, 32 : 904 - 912
  • [3] Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer
    Hussain, Maha
    Carducci, Michael A.
    Slovin, Susan
    Cetnar, Jeremy
    Qian, Jiang
    McKeegan, Evelyn M.
    Refici-Buhr, Marion
    Chyla, Brenda
    Shepherd, Stacie P.
    Giranda, Vincent L.
    Alumkal, Joshi J.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (05) : 904 - 912
  • [4] Compensatory activation of alternative DNA repair pathways following exposure to the PARP Inhibitor ABT-888 in vitro and in patients with solid malignancies
    Gao, Li
    Duan, Wenrui
    Wu, Xin
    Chen, Alice
    Otterson, Gregory A.
    Villalona, Miguel A.
    CANCER RESEARCH, 2012, 72
1